Deborah Birx
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Deborah Birx
Deborah Birx is recorded as CEO at Armata Pharmaceuticals, Inc. (ARMP). Armata Pharmaceuticals, Inc. reported in an 8-K filed July 11, 2023 that Deborah Birx was appointed Chief Executive Officer, effective July 10, 2023. The proxy statement of Armata Pharmaceuticals, Inc. reports total compensation of $1,584,176 for Deborah Birx in fiscal 2024, including a base salary of $546,000. Disclosed compensation is on record for 2 fiscal years.
“We are pleased to confirm our offer of employment with Armata Pharmaceuticals, Inc. (the "Company" and together with its direct and indirect subsidiaries, the "Company Group") in the position of Chief Executive Officer ("CEO"), effective as of the termination of employment of the Company Group's current Chief Executive Officer on July 10, 2023 (the "Commencement Date") on the terms set forth in this letter agreement (the "Agreement").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-07-10–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Armata Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Deborah L. Birx CEO, Board Member
- Dr. Deborah Birx CEO, Board Member
- Richard J. Bastiani Chairman
- David House CFO
- Julianne Averill CFO
- Richard Rychlik CFO
- Erin Butler Chief Accounting Officer
- Daniel Gilmer Board Member
- Dr. Daniel Gilmer Board Member
- Joseph M. Patti Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Armata Pharmaceuticals, Inc. (ARMP) | Chief Executive Officer | $546,000 | $1,584,176 |
| 2023 | Armata Pharmaceuticals, Inc. (ARMP) | Chief Executive Officer | $251,563 | $1,133,931 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.